CRISPR Therapeutics
The Senior Scientist, Analytical Development at CRISPR Therapeutics will lead the development, implementation, and qualification of cell‑based assays, overseeing technology transfers and regulatory documentation. The role involves managing a team, ensuring assay performance, and supporting cross‑functional product development initiatives.
Headquarters
Boston, Massachusetts, United States
Company Size
201-500 employees
Founded
2013
CRISPR Therapeutics is a gene-editing company pioneering the development of transformative medicines using CRISPR/Cas9 technology to treat serious diseases. The company has a broad pipeline spanning hemoglobinopathies, immuno-oncology, autoimmune diseases, in vivo editing, and regenerative medicine, including CASGEVY™, the first-ever approved CRISPR-based therapy for sickle cell disease and transfusion-dependent beta thalassemia. CRISPR Therapeutics operates across multiple clinical and preclinical programs in collaboration with partners such as Vertex Pharmaceuticals.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for CRISPR Therapeutics.
23% above the average for this role
CRISPR Therapeutics’ CASGEVY Progress Reframes Growth And Valuation Story
2 days ago
Senior Scientist I, Analytical Development, Biologics CMC
Exelixis
Bioassay Scientist
Eurofins
Scientist, Analytical Cell Line Engineering & Bioassay Development
BioLife Plasma Services
Senior Biologist
Keenova
Cell Potency Analytical Development Lead
Artiva Biotherapeutics
Assay Development Scientist
NeoGenomics Laboratories